DK24595A - 8-alkoxy-1,2,3,3a,8,8a-hexahydro-indeno[1,2-a]-pyrrol- og 9-alkoxy-2,3,3a,4,5,9b-hexahydro-1H-benz[e]isoindolforbindelser, farmaceutiske midler indeholdende disse samt anvendelsen heraf til fremstilling af lægemidler til behandling af hypertension - Google Patents

8-alkoxy-1,2,3,3a,8,8a-hexahydro-indeno[1,2-a]-pyrrol- og 9-alkoxy-2,3,3a,4,5,9b-hexahydro-1H-benz[e]isoindolforbindelser, farmaceutiske midler indeholdende disse samt anvendelsen heraf til fremstilling af lægemidler til behandling af hypertension Download PDF

Info

Publication number
DK24595A
DK24595A DK024595A DK24595A DK24595A DK 24595 A DK24595 A DK 24595A DK 024595 A DK024595 A DK 024595A DK 24595 A DK24595 A DK 24595A DK 24595 A DK24595 A DK 24595A
Authority
DK
Denmark
Prior art keywords
alkoxy
hexahydro
indeno
benz
hypertension
Prior art date
Application number
DK024595A
Other languages
English (en)
Inventor
John F Debernardis
Michael D Meyer
Kevin B Sippy
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of DK24595A publication Critical patent/DK24595A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/62—Naphtho [c] pyrroles; Hydrogenated naphtho [c] pyrroles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Networks Using Active Elements (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Amplifiers (AREA)
  • Battery Electrode And Active Subsutance (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Read Only Memory (AREA)
  • Manipulation Of Pulses (AREA)
  • Logic Circuits (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK024595A 1988-12-15 1995-03-10 8-alkoxy-1,2,3,3a,8,8a-hexahydro-indeno[1,2-a]-pyrrol- og 9-alkoxy-2,3,3a,4,5,9b-hexahydro-1H-benz[e]isoindolforbindelser, farmaceutiske midler indeholdende disse samt anvendelsen heraf til fremstilling af lægemidler til behandling af hypertension DK24595A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28513488A 1988-12-15 1988-12-15

Publications (1)

Publication Number Publication Date
DK24595A true DK24595A (da) 1995-03-10

Family

ID=23092880

Family Applications (2)

Application Number Title Priority Date Filing Date
DK194490A DK171061B1 (da) 1988-12-15 1990-08-15 Hexahydro-1H-indeno(2,1-c)pyridinforbindelser, farmaceutiske midler indeholdende disse samt anvendelsen heraf til fremstilling af lægemidler til behandling af hypertension, ængstelse eller depression
DK024595A DK24595A (da) 1988-12-15 1995-03-10 8-alkoxy-1,2,3,3a,8,8a-hexahydro-indeno[1,2-a]-pyrrol- og 9-alkoxy-2,3,3a,4,5,9b-hexahydro-1H-benz[e]isoindolforbindelser, farmaceutiske midler indeholdende disse samt anvendelsen heraf til fremstilling af lægemidler til behandling af hypertension

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK194490A DK171061B1 (da) 1988-12-15 1990-08-15 Hexahydro-1H-indeno(2,1-c)pyridinforbindelser, farmaceutiske midler indeholdende disse samt anvendelsen heraf til fremstilling af lægemidler til behandling af hypertension, ængstelse eller depression

Country Status (10)

Country Link
EP (1) EP0422134B1 (da)
JP (1) JPH03502701A (da)
KR (1) KR910700251A (da)
AT (1) ATE139230T1 (da)
AU (1) AU626621B2 (da)
CA (1) CA2005441A1 (da)
DE (1) DE68926673T2 (da)
DK (2) DK171061B1 (da)
ES (1) ES2090119T3 (da)
WO (1) WO1990006927A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9014061D0 (en) * 1990-06-25 1990-08-15 Merck Sharp & Dohme Therapeutic agents
CA2118920A1 (en) * 1991-10-24 1993-04-29 Arthur G. Romero Benzo-isoquinoline derivatives and analogs and their use in therapeutics
EP0539209A1 (en) * 1991-10-24 1993-04-28 The Upjohn Company Benzo-isoquinoline derivatives and analogs and their use in therapeutics
US5512566A (en) * 1993-10-25 1996-04-30 Ortho Pharmaceutical Corporation Tricyclic compounds having affinity for the 5-HT1A receptor
KR950014099A (ko) * 1993-11-10 1995-06-15 장기하 N-(2-피리미딜)피페라지닐 부틸아미드의 제조방법
FR2722194B1 (fr) * 1994-07-06 1996-08-23 Adir Nouveaux derives de benzopyrane, leur procede de preparation et les compositions pharmacuetiques qui les contiennent
WO2002044159A2 (en) 2000-11-29 2002-06-06 Eli Lilly And Company 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine and pharmaceutically acceptable salts and solvates thereof and their use in the treatment of incontinence
US20060025601A1 (en) * 2004-07-29 2006-02-02 Athersys, Inc. Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators
TW200924752A (en) * 2007-09-17 2009-06-16 Organon Nv Tricyclic heterocyclic derivatives
TW201041851A (en) 2009-03-10 2010-12-01 Organon Nv Tricyclic heterocyclic derivatives
US8546377B2 (en) 2009-04-23 2013-10-01 Abbvie Inc. Modulators of 5-HT receptors and methods of use thereof
US8518933B2 (en) 2009-04-23 2013-08-27 Abbvie Inc. Modulators of 5-HT receptors and methods of use thereof
ES2423668T3 (es) 2009-05-22 2013-09-23 Abbvie Inc. Moduladores de receptores 5-HT y métodos de uso de los mismos
WO2011146089A1 (en) 2010-05-21 2011-11-24 Abbott Laboratories Modulators of 5-ht receptors and methods of use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792374A (fr) * 1971-12-08 1973-06-06 Allen & Hanburys Ltd Nouveaux derives d'isoindoline
US4341786A (en) * 1981-03-02 1982-07-27 Smithkline Corporation Pharmaceutical compositions and method of producing central alpha1 agonist activity utilizing octahydrobenzo[f]quinoline compounds
US4438346A (en) * 1981-10-15 1984-03-20 Advanced Micro Devices, Inc. Regulated substrate bias generator for random access memory
US4618683A (en) * 1982-06-01 1986-10-21 Abbott Laboratories Tetrahydro-6,7-dimethoxy-1H-benz[e]isoinodolines useful in the treatment of hypertension and as sedatives
AU560459B2 (en) * 1982-06-01 1987-04-09 Abbott Laboratories Tetrahydro-benzo(e) isoindolines
SE8302361D0 (sv) * 1983-04-27 1983-04-27 Astra Laekemedel Ab New tricyclic amines
DE3401931C2 (de) * 1984-01-20 1986-06-12 Continental Gummi-Werke Ag, 3000 Hannover Biegsamer Schlauch
DE3576334D1 (de) * 1984-07-25 1990-04-12 Abbott Lab 1,2,3,3a,8,8a-hexahydro-indeno-(1,2-c)pyrrde.
DE3522959A1 (de) * 1985-06-27 1987-01-08 Merck Patent Gmbh Indolderivate
US4842852A (en) * 1988-03-10 1989-06-27 National Starch And Chemical Corporation Hydrocarbon tolerant hair fixing compositions

Also Published As

Publication number Publication date
DK171061B1 (da) 1996-05-13
EP0422134A4 (en) 1992-05-06
DE68926673D1 (de) 1996-07-18
AU626621B2 (en) 1992-08-06
ES2090119T3 (es) 1996-10-16
DE68926673T2 (de) 1997-01-16
CA2005441A1 (en) 1990-06-15
ATE139230T1 (de) 1996-06-15
EP0422134A1 (en) 1991-04-17
DK194490D0 (da) 1990-08-15
AU4746090A (en) 1990-07-10
DK194490A (da) 1990-10-12
EP0422134B1 (en) 1996-06-12
WO1990006927A1 (en) 1990-06-28
JPH03502701A (ja) 1991-06-20
KR910700251A (ko) 1991-03-14

Similar Documents

Publication Publication Date Title
FI960399A7 (fi) Perhydroisoindolijohdannaisia P-aineen antagonisteina
NO20003534L (no) Progesteronreseptor-modulatorforbindelser, farmasøytiske sammensetninger inneholdende disse og anvendelsen av forbindelsene
ATE172971T1 (de) Heterocyclische neurokinin-antagonisten
DK0807111T3 (da) Substituerede heterocykliske forbindelser, fremgangsmåde til fremstillingen heraf samt farmaceutiske sammensætninger indeholdende disse
ATE226247T1 (de) Menschliche neuronale nikotin-acetylcholin- rezeptor-verbindungen und methoden ihres einsatzes
ITMI930699A0 (it) Nuovi derivati dell'indolo
ATE90093T1 (de) 1,3,4,5-tetrahydrobenz(c,d>indole.
ES2090119T3 (es) Agentes selectivos de 5-ht.
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
NO963331D0 (no) 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister
IL79264A0 (en) Tryptamine derivatives,pharmaceutical compositions containing them and their use in an assay for melatonin receptors
DE69703242D1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
FI960571A7 (fi) Kolekystokiniini- ja gastriiniantagonisteina käyttökelpoisia bisyklo(2.2.2)oktaanijohdannaisia
NO911200L (no) Fremgangsmaate for fremstilling av selektive adenosin-receptor midler.
DE69328779D1 (de) Benzodiazepin-derivate sowie deren konjugate mit proteinen und polypeptiden
DE69406425D1 (de) Trizyklische heterozyklische verbindungen als 5-ht4 rezeptorantagonisten
FI943807L (fi) Pyratsolopyrimidiinijohdannaisia angiotensiini II:n reseptoreiden vastavaikuttajina
FI931881A7 (fi) Merkityt fibrinogeeni-reseptori-antagonistit, niiden käyttö ja menetelmä niiden valmistamiseksi
DE69717449D1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
DE69516467D1 (de) Feste Lösungen von Pyrrolo-(3,4-c)-pyrrolen mit Chinacridonchinonen
DK115289D0 (da) Tricykliske aminderivater, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende disse
GR890100826A (en) Method of preparation of s-ht selective agents
DK590984D0 (da) Pyrrolo(3,2,1-hi)indol-derivater, fremgangsmaade til fremstilling deraf samt anvendelse af saadanne forbindelser som laegemidler
ATE82851T1 (de) Radioaktiv markierte benzodiazepinderivate.
IT8919648A0 (it) Derivati dell'indolo, procedimento per la loro preparazione e mezzi farmaceutici contenenti tali composti.